RECODE-DCM

Welcome to RECODE-DCM, the Research Arm of Myelopathy.org

RECODE-DCM stands for “REsearch objectives and COmmon Data Elements for Degenerative Cervical Myelopathy”.
RECODE-DCM acts as a community, to accelerate the creation and translation of knowledge that can improve outcomes. The participants are Myelopathy.org’s community of people with DCM, alongside world leaders from diverse stakeholder groups: general practitioners, bench scientists, medical students, physiotherapists, osteopaths, occupational therapists, surgeons, healthcare economists, politicians, and more. This combination of lived experience and professional experience gives RECODE-DCM unique relevance and power.
RECODE-DCM started in 2019 as a consensus project to improve research efficiency in DCM [1]. It was conceived by Dr Mark Kotter and Dr Benjamin Davies. 
The AO Spine Spinal Cord Injury Knowledge Forum, Chaired at the time by Dr Michael Fehlings, recognised the huge global burden of DCM. AO Spine therefore provided funding to kickstart the initiative, for which we are forever grateful.
Dr Michael Fehlings Articulates the Problem
The group recognised that existing DCM research had many shortcomings: 
studies were duplicated (they repeated the same research question)
studies were difficult to generalise (they measured different outcomes, at different time points, using different tools, and failed to account for key baseline determinants)
studies focused on aspects of the disease that were immaterial to people living with DCM (the research focus was not aligned with the needs of those with lived experience of DCM or those who care for them)
RECODE-DCM initially addressed these shortcomings by: 
In 2019, establishing the top unanswered research questions, ranked according to priority
In 2020, establishing a standardised set of baseline characteristics and outcomes that should be measured in DCM research
In 2020, establishing the index term and its definition
In 2022, establishing the key measurement tools to evaluate DCM in all research going forward
RECODE-DCM Continues
To meet these objectives, a diverse and global community of people living or working with DCM was formed.  This was a unique community, and the dividends of bringing such a group together was seen in the many unplanned outputs that followed, including the selection of Person First Language or proposing a new framework for our understanding of DCM.

Recognising the potential for such a community to continue to tackle challenges in both the creation and translation of knowledge in DCM, Myelopathy.org took on responsibility for it.  This was initially focused on the formation of specialist working groups tackling key research priorities, termed Incubators.  In 2025 AO Spine has returned to support Myelopathy.org with these and additional working groups, as we tackle a new set of key challenges under the leadership of Dr Benjamin Davies.  The project is called RECODE-DCM 2.       
Watch the Video to Understand the Evolution of RECODE-DCM

We look forward to renewing this partnership in 2025, and continuing to foster the collaborative solutions needed to make Myelopathy Matter.
The participants at the Core Measurement Set consensus meeting, kindly hosted by AO Spine at the Global Spine Congress 2022 in Las Vegas. Back row, left to right, Allan Martin, Nader Fallah, Olesja Hazenbiller, Lindsay Tetreault, David Anderson, Alvaro Yanez Touzet, Timothy Boerger, Caroline Treanor. Front row, left to right, James Guest, Brian Kwon, Benjamin Davies, Mark Kotter, Lisa Petermann, Tammy Blizzard

Our Partners